U.S. Microfluidics Market Size & Outlook, 2023-2030
U.S. microfluidics market, 2018-2030 (US$M)
Related Markets
U.S. microfluidics market highlights
- The U.S. microfluidics market generated a revenue of USD 12,489.9 million in 2023 and is expected to reach USD 25,282.1 million by 2030.
- The U.S. market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, medical was the largest revenue generating technology in 2023.
- Medical is the most lucrative technology segment registering the fastest growth during the forecast period.
Microfluidics market data book summary
| Market revenue in 2023 | USD 12,489.9 million |
| Market revenue in 2030 | USD 25,282.1 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Medical |
| Fastest growing segment | Medical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Medical, Non-Medical |
| Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 38.9% of the global microfluidics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. microfluidics market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 2,570.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Microfluidics Market Scope
Microfluidics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. microfluidics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 83.98% in 2023. Horizon Databook has segmented the U.S. microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.
The demand for microfluidics devices is high in the U.S. owing to increasing research undertaken, government funding, and favorable policies. For instance, MEI Lab announced that it was developing organ-on-a-chip digital twin platforms, as well as 3D implantable and transformable electrodes.
The scope of this multiyear project includes assembling 3D structures, optimizing & screening functional materials, and assessing their biocompatibility. Moreover, the FDA’s Center for Devices and Radiological Health (CDRH) is also seeking to advance innovation in medical devices based on microfluidics by developing a regulatory science tool for leakage testing.
Furthermore, microfluidics entails high levels of skill, and therefore, simplifying through machine learning and AI can encourage its broader use in life sciences and healthcare. For instance, Deepcell, with its AI-based single-cell sorting and analysis technology, is among the first companies to bring the combination of machine learning, AI, and microfluidics into the commercial domain.
Reasons to subscribe to U.S. microfluidics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. microfluidics market databook
-
Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. microfluidics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. microfluidics market size, by technology, 2018-2030 (US$M)
U.S. Microfluidics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
